TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Assisted Reproductive Technology (ART) Market, by Diagnosis
6.1 Introduction
6.2 Ovulation Testing
6.3 Hysterosalpingography.
6.4 Ovarian Reserve Testing
6.5 Genetic Testing
6.6 Other hormone testing
6.7 Imaging tests
Chapter 7. Global Assisted Reproductive Technology (ART) Market, by Type
7.1 Introduction
7.2 Ovulation Induction (OI)
7.3 Artificial Insemination (AI)
7.4 Donor Conception
7.5 In-Vitro Fertilization (IVF)
7.6 Gamete Intrafallopian Transfer (GIFT)
7.7 Intracytoplasmic Sperm Injection (ICSI)
7.8 Preimplantation Genetic Diagnosis (PGD)
7.9 Surrogacy
Chapter 8. Global Assisted Reproductive Technology (ART) market, by End-User
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Ambulatory Surgical Centers
8.4 Diagnostic Centers
8.5 Gynecology Centers
8.6 Feminist Health Centers
8.7 IVF Centers
Chapter 9. Global Assisted Reproductive Technology (ART) Market, by Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of the Middle East & Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Cosmos Biomedical Limited
11.1.1 Company Overview
11.1.2 Type Overview
11.1.3 Financials
11.2.4 Key Developments
11.1.5 SWOT Analysis
11.2 California Cryobank
11.2.1 Company Overview
11.2.2 Type Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Bloom IVF Centre
11.3.1 Company Overview
11.3.2 Type Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Cryolab Ltd
11.4.1 Company Overview
11.4.2 Type/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Parallabs
11.5.1 Company Overview
11.5.2 Type Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 OvaScience
11.6.1 Company Overview
11.6.2 Type Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Anecova
11.7.1 Overview
11.7.2 Type Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Merck KGaA
11.8.1 Overview
11.8.2 Type Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 CooperSurgical Inc.
11.9.1 Overview
11.9.2 Type Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Ferring Pharmaceuticals
11.10.1 Overview
11.10.2 Type Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 European Sperm Bank
11.11.1 Overview
11.11.2 Type Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Irvine Scientific
11.12.1 Overview
11.12.2 Type Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Hamilton Throne Ltd
11.13.1 Overview
11.13.2 Type Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 Microm Ltd
11.14.1 Overview
11.14.2 Type Overview
11.14.3 Financials
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.15 Others
Chapter 12 Appendix
LIST OF TABLES
Table 1 Assisted Reproductive Technology (ART) Market Industry Synopsis, 2020-2027
Table 2 Global Assisted Reproductive Technology (ART) Market Estimates & Forecast, 2020-2027, (USD Million)
Table 3 Global Assisted Reproductive Technology (ART) Market, by Region, 2020-2027, (USD Million)
Table 4 Global Assisted Reproductive Technology (ART) Market, by Diagnosis, 2020-2027, (USD Million)
Table 5 Global Assisted Reproductive Technology (ART) Market, by Type, 2020-2027, (USD Million)
Table 6 Global Assisted Reproductive Technology (ART) Market, by End-User, 2020-2027, (USD Million)
Table 7 North America Assisted Reproductive Technology (ART) Market, by Diagnosis, 2020-2027, (USD Million)
Table 8 North America Assisted Reproductive Technology (ART) Market, by Type, 2020-2027, (USD Million)
Table 9 North America Assisted Reproductive Technology (ART) Market, by End-User, 2020-2027, (USD Million)
Table 10 US Assisted Reproductive Technology (ART) Market, by Diagnosis, 2020-2027, (USD Million)
Table 11 US Assisted Reproductive Technology (ART) Market, by Type, 2020-2027, (USD Million)
Table 12 US Assisted Reproductive Technology (ART) Market, by End-User, 2020-2027, (USD Million)
Table 13 Canada Assisted Reproductive Technology (ART) Market, by Diagnosis, 2020-2027, (USD Million)
Table 14 Canada Assisted Reproductive Technology (ART) Market, by Type, 2020-2027, (USD Million)
Table 15 Canada Assisted Reproductive Technology (ART) Market, by End-User, 2020-2027, (USD Million)
Table 16 South America Assisted Reproductive Technology (ART) Market, by Diagnosis, 2020-2027, (USD Million)
Table 17 South America Assisted Reproductive Technology (ART) Market, by Type, 2020-2027, (USD Million)
Table 18 South America Assisted Reproductive Technology (ART) Market, by End-User, 2020-2027, (USD Million)
Table 19 Europe Assisted Reproductive Technology (ART) Market, Diagnosis, 2020-2027, (USD Million)
Table 20 Europe Assisted Reproductive Technology (ART) Market, by Type, 2020-2027, (USD Million)
Table 21 Europe Assisted Reproductive Technology (ART) Market, by End-User, 2020-2027, (USD Million)
Table 22 Western Europe Assisted Reproductive Technology (ART) Market, by Diagnosis, 2020-2027, (USD Million)
Table 23 Western Europe Assisted Reproductive Technology (ART) Market, by Type, 2020-2027, (USD Million)
Table 24 Western Europe Assisted Reproductive Technology (ART) Market, by End-User, 2020-2027, (USD Million)
Table 25 Eastern Europe Assisted Reproductive Technology (ART) Market, by Diagnosis, 2020-2027, (USD Million)
Table26 Eastern Europe Assisted Reproductive Technology (ART) Market, by Type, 2020-2027, (USD Million)
Table 27 Eastern Europe Assisted Reproductive Technology (ART) Market, by End-User, 2020-2027, (USD Million)
Table 28 Asia-Pacific Assisted Reproductive Technology (ART) Market, by Diagnosis, 2020-2027, (USD Million)
Table 29 Asia-Pacific Assisted Reproductive Technology (ART) Market, by Type, 2020-2027, (USD Million)
Table 30 Asia-Pacific Assisted Reproductive Technology (ART) Market, by End-User, 2020-2027, (USD Million)
Table 31 Middle East & Africa Assisted Reproductive Technology (ART) Market, by Diagnosis, 2020-2027, (USD Million)
Table 32 Middle East & Africa Assisted Reproductive Technology (ART) Market, by Type, 2020-2027, (USD Million)
Table 33 Middle East & Africa Assisted Reproductive Technology (ART) Market, by End-User, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Assisted Reproductive Technology (ART) Market
Figure 3 Market Dynamics for Global Assisted Reproductive Technology (ART) Market
Figure 4 Global Assisted Reproductive Technology (ART) Market Share, by Diagnosis 2020
Figure 5 Global Assisted Reproductive Technology (ART) Market Share, by Type 2020
Figure 6 Global Assisted Reproductive Technology (ART) Market Share, by End-User, 2020
Figure 7 Global Assisted Reproductive Technology (ART) Market Share, by Region, 2020
Figure 8 North America Assisted Reproductive Technology (ART) Market Share, by Country, 2020
Figure 9 Europe Assisted Reproductive Technology (ART) Market Share, by Country, 2020
Figure 10 Asia-Pacific Assisted Reproductive Technology (ART) Market Share, by Country, 2020
Figure 11 Middle East & Africa Assisted Reproductive Technology (ART) Market Share, by Country, 2020
Figure 12 Global Assisted Reproductive Technology (ART) Market: Company Share Analysis, 2020 (%)
Figure 13 COSMOS BIOMEDICAL LIMITED: Key Financials
Figure 14 COSMOS BIOMEDICAL LIMITED: Segmental Revenue
Figure 15 COSMOS BIOMEDICAL LIMITED: Geographical Revenue
Figure 16 California Cryobank: Key Financials
Figure 17 California Cryobank: Segmental Revenue
Figure 18 California Cryobank: Geographical Revenue
Figure 19 Bloom IVF Centre: Key Financials
Figure 20 Bloom IVF Centre: Segmental Revenue
Figure 21 Bloom IVF Centre: Geographical Revenue
Figure 22 Cryolab Ltd: Key Financials
Figure 23 Cryolab Ltd: Segmental Revenue
Figure 24 Cryolab Ltd: Geographical Revenue
Figure 25 OvaScience: Key Financials
Figure 26 OvaScience: Segmental Revenue
Figure 27 OvaScience: Geographical Revenue
Figure 28 Parallabs: Key Financials
Figure 29 Parallabs: Segmental Revenue
Figure 30 Parallabs: Geographical Revenue
Figure 31 Anecova. : Key Financials
Figure 32 Anecova. : Segmental Revenue
Figure 33 Anecova. : Geographical Revenue
Figure 34 Merck KGaA: Key Financials
Figure 35 Merck KGaA: Segmental Revenue
Figure 36 Merck KGaA: Geographical Revenue
Figure 37 CooperSurgical Inc.: Key Financials
Figure 38 CooperSurgical Inc.: Segmental Revenue
Figure 39 CooperSurgical Inc.: Geographical Revenue
Figure 40 Ferring Pharmaceuticals: Key Financials
Figure 41 Ferring Pharmaceuticals: Segmental Revenue
Figure 42 Ferring Pharmaceuticals: Geographical Revenue
Figure 46 Irvine Scientific .: Key Financials
Figure 47 Irvine Scientific .: Segmental Revenue
Figure 48 Irvine Scientific .: Geographical Revenue
Figure 49 Hamilton Throne Ltd: Key Financials
Figure 50 Hamilton Throne Ltd: Segmental Revenue
Figure 51 Hamilton Throne Ltd: Geographical Revenue
Figure 52 Microm Ltd: Key Financials
Figure 53 Microm Ltd: Segmental Revenue
Figure 54 Microm Ltd: Geographical Revenue
Assisted Reproductive Technology Market
According to the MRFR reports, the global assisted reproductive technology market will register a healthy CAGR & USD over the forecasted era.
$48.06 Billion
Market Size
10.3%
CAGR
Europe
Dominating Region
2022-2030
Forecast Period
Segmentation
Key Players
- Cosmos Biomedical Limited
- California Cryobank
- Bloom IVF Centre
- Cryolab Ltd.
- Parallabs
- OvaScience
- Anecova
Drivers
- Growing obesity among women
- Increase in ovulation disorders
- Change to sedentary lifestyle
- Growing consumption of unhealthy diet
Assisted Reproductive Technology Market Overview
According to the MRFR reports, the global assisted reproductive technology market will register a healthy CAGR of over 10% over the forecasted era.
Reproductive technology like surrogacy, in vitro fertilization, and fertility medication used to treat infertility amongst women, is called assisted reproductive technology. The roots of infertility in women may be cancer, fallopian tube damage or blockage, ovulation disorders, endometriosis, uterine or cervical abnormalities, and others. In addition, lifestyle factors such as lack of physical inactivity, alcohol consumption, smoking tobacco or marijuana, and being overweight can also lead to infertility. The global market for assisted reproductive technology has registered enormous growth in the last few years. The market's growth is mainly being driven by the rising prevalence of infertility across the globe. Furthermore, the factors such as the surge in smoking and alcohol consumption, growing occurrence of Polycystic Ovarian Syndrome (PCOS), change to sedentary lifestyle, rising obesity among women, growing occurrence of ovarian and endometrial cancer, mounting consumption of unhealthy diet, and rise in ovulation disorders are also projected to catalyze the market's growth over the assessment era. On the other hand, factors such as side effects associated with hysterectomy procedures, the risk of prematurity & low birth weight in newborns, raising ethical issues, high cost of assisted reproductive technology procedures, and chances of congenital disabilities are likely to impede the market's growth in the coming years.
Assisted Reproductive Technology Market Segmentation
The assisted reproductive technology market has been segmented on the basis of diagnosis, type, end-user.
On the basis of diagnosis, the market assisted reproductive technology market has been classified as ovulation testing, hysterosalpingography and other.
On the basis of technique type, the market is classified into ovulation induction, artificial insemination, surrogacy and others.
On the basis of end-user, the market is divided hospitals & clinics, IVF center and others
On the basis of region, the global assisted reproductive technology market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Assisted Reproductive Technology Market-Key players
Some of the key players in the global assisted reproductive technology market are Cosmos Biomedical Limited, California Cryobank, Bloom IVF Centre, Cryolab Ltd., Parallabs, OvaScience, Anecova, Origio, Microm Ltd., Merck KGaA, Cooper Surgical, Inc, Ferring Pharmaceuticals, European Sperm Bank, Irvine Scientific and Hamilton Throne Ltd.
Assisted Reproductive Technology Market Regional Market Summary
It is estimated that Europe dominated the global assisted reproductive technology market owing to the increasing innovations in clinical practice and access to fertility treatment in this region. According to the Human Fertilization and Embryology Authority UK in 2016, there were 68,000 IVF treatment cycles, resulting in 20,028 births through IVF treatment. Thus, the increasing infertility treatments in this region influences the growth of this market in this region.
North America stood second in the assisted reproductive technology (ART) market owing to the rising prevalence of obesity. Obesity affects fertility rate as it causes hormonal imbalances and problems with ovulation, thus women who suffer from obesity have fewer chances of conceiving. Obesity in males also affects the sperm count and sperm quality thus increasing male infertility. According to the National Health and Nutrition Examination Survey (NHANES), 2014, 70.2% of the total U.S. adults were overweight. Other factors such as increasing healthcare expenditure and increasing technological advancements in assisted reproductive technology (ART) drive the market growth in this region.
Asia-Pacific was projected to be the fastest growing region for the global assisted reproductive technology market in 2017. The market is expected to witness growth owing to the rising prevalence of infertility in women, changing lifestyle, and growing obesity within the population. According to the United Nations report in 2013, the main factor for low fertility in Asia is a postponement of marriage and delayed childbearing.
The Middle East and Africa holds the least share in the global assisted reproductive technology market due to the presence of stringent government policies and poor economies. However, the market is expected to witness growth due to the development of infertility treatment and increased numbers of IVF centers in this region. Also, governmental support, partial or full insurance coverage of treatment cost, social and religious values of childbearing and the role of children in family stability in the Middle East influence the assisted reproductive technology devices market growth in this region.
Recent Development
- February 2022- Cooper Companies, a Medical device company, has announced a binding agreement to purchase Cook Medical's Reproductive Health business in a USD875m deal. As per the terms of the contract, the firm will pay USD675m at the time of closing and a further USD200m in four annual installments of USD50m each.
- December 2021- a medical device company concentrated on marketing the only in vivo culture system (IVC) across the globe, INVOcell®, INVO Bioscience, Inc., has announced the signing of an expansion agreement with a group of clinics focused in specializing in assisted reproductive treatments with four locations in Spain, Ovoclinic, and partnering centers across Europe, to boost adoption of INVOcell within their markets.
Assisted Reproductive Technology Market Segmentation
Global Assisted Reproductive Technology Market, by Diagnosis
- Ovulation Testing
- Hysterosalpingography
- Ovarian Reserve Testing
- Genetic Testing
- Other hormone testing
- Imaging tests
Global Assisted Reproductive Technology Market, by Type
- Ovulation Induction (OI)
- Artificial Insemination (AI)
- Donor Conception
- In-Vitro Fertilization (IVF)
- Gamete Intrafallopian Transfer (GIFT)
- Intracytoplasmic Sperm Injection (ICSI)
- Preimplantation Genetic Diagnosis (PGD)
- Surrogacy
Global Assisted Reproductive Technology market, by End-User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- Gynecology Centers
- Feminist Health Centers
- IVF Centers
Global Assisted Reproductive Technology Market, by Region
- Americas
- Europe
- Asia-Pacific
- Middle East & Africa
Intended Audience
- Pharmaceutical companies
- Biotechnological institutes
- Government and private laboratories
- Research and Development (R&D) companies
- Medical research laboratories
- Market research and consulting service providers
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant value |
| CAGR | 2018-2027: ~10% |
| Base Year | 2019 |
| Forecast Period | 2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Diagnosis, Type, and End-User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Some of the key players in the global assisted reproductive technology (ART) market are Cosmos Biomedical Limited, California Cryobank, Bloom IVF Centre, Cryolab Ltd., Parallabs, OvaScience, Anecova, Origio, Microm Ltd., Merck KGaA, Cooper Surgical, Inc, Ferring Pharmaceuticals, European Sperm Bank, Irvine Scientific and Hamilton Throne Ltd |
| Key Market Opportunities | Innovations in clinical practice and access to fertility treatment |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
The types of Assisted Reproductive Technology (ART) are Ovulation Induction, Artificial Insemination, Surrogacy.
Europe is expected to lead the Assisted Reproductive Technology Market.
Increasing prevalence of infertility and PCOS is boosting market growth.
High treatment cost and certain side effects may limit market growth.
Key competitors in the Assisted Reproductive Technology Market include Hamilton Throne Ltd, Irvine Scientific, European Sperm Bank, Ferring Pharmaceuticals, Cooper Surgical, Inc, Merck KGaA, Microm Ltd., Origio, Anecova, OvaScience, Parallabs, Cryolab Ltd., Bloom IVF Centre, California Cryobank, and Cosmos Biomedical Limited.
Assisted Reproductive Technology Market is projected to grow at a 10% CAGR between 2018-2023.
Assisted Reproductive Technology Market is projected to grow at a 10% CAGR between 2018-2023.
